8-K 1 alo8kcontroller.htm SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________



FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

________________
 


Date of Report (Date of earliest event reported):
June 28, 2005

Alpharma Inc.
 

(Exact name of registrant as specified in its charter)
 

Delaware
(State or other jurisdiction of incorporation)

1-8593
(Commission File
Number)

22-2095212
(IRS Employer Identification)
 

One Executive Drive, Fort Lee, New Jersey 07024
(Address of principal executive offices) (Zip Code)
 

Registrant's telephone number, including area code
(201) 947-7774
 
 

Not Applicable

______________________________________________
(Former name or former address, if changed since

last report)

 

 

 

 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
  1. Resignation of Principal Accounting Officer

    2. Effective June 28, 2005, Jeffrey S. Campbell, resigned from his position as Controller and Principal Accounting Officer of the registrant. He has been appointed Vice President, Finance of the registrant and will be the supervisor of the newly appointed Controller.

  2. Appointment of New Controller and Principal Accounting Officer

Effective June 28, 2005, John F. Konzelmann, age 57, joined the registrant as Vice President, Controller. In this position, Mr. Konzelmann will also serve as Principal Accounting Officer. Mr. Konzelmann served as Assistant Corporate Controller and Director of Financial Reporting of Unilever United States Inc. from 2000 until April 2004. From 1994 to 2000 Mr. Konzelmann served as Assistant Corporate Controller of Bestfoods, prior to Unilever's acquisition of Bestfoods.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 
 

ALPHARMA INC.
 

By: /s/ Matthew Farrell

 

Name: Matthew Farrell

Title: Executive Vice President and CFO
   

Date: July 1, 2005